Carotid-cavernous fistulae (CCFs) are abnormal communications between the carotid artery and cavernous sinus that may present with rapid visual deterioration and extraocular paresis as a result of increasing intraocular pressure requiring emergent treatment to preserve vision. We present a technique of balloonassisted ethanol embolization of the cavernous carotid artery supply to indirect CCFs providing immediate reduction in intraocular pressure with symptomatic improvement.
A fistula is a direct connection between an artery and a vein. Carotidcavernous fistulae (CCFs) form secondary to abnormal communications between the carotid artery and cavernous sinus and may present with pulsatile exophthalmos, bruit, diplopia, chemosis, pain, increased intraocular pressure (IOP), and/or erythema. Barrow et al. (2) classified CCFs as direct (Type A) or dural (indirect; Types B-D). Direct CCFs are high-flow fistulae caused by traumatic or aneurysmal rupture of the cavernous carotid artery into the cavernous sinus. Indirect or dural CCFs are low-flow states caused by anomalous connections between the cavernous sinus and smaller-caliber branches of the cavernous carotid artery, external carotid artery, or both. These lesions present most commonly in perimenopausal women and have been attributed to a number of causes, including congenital abnormalities, spontaneous venous hypertension from thrombosis, atherosclerosis, angiopathy from collagen vascular disorders, syphilitic arteritis, and iatrogenic vessel damage (13) . Indirect CCFs occasionally resolve spontaneously or respond to serial manual carotid compression. Treatment is indicated for worsening symptoms, medically refractory increased IOP, or the presence of angiographic features associated with increased risk of hemorrhage, such as pseudoaneurysm, large varices, or cortical venous drainage (6) . Man-agement options include balloon occlusion; arterial embolization of external carotid artery (ECA) and internal carotid artery (ICA) feeders with polyvinyl alcohol, 50% dextrose, or cyanoacrylates; transvenous coil embolization of the cavernous sinus; surgical obliteration; and stereotactic radiosurgery (1, 2, 5, 8, 9, 11, 16) . When indirect CCFs cause deterioration in visual function from increased IOP, urgent treatment is necessary. We present a retrospective analysis of six patients treated with absolute ethanol embolization of the cavernous carotid supply to indirect CCFs, resulting in an immediate decrease in IOPs and symptomatic improvement.
PATIENTS AND METHODS
Between November 1999 and March 2001, six patients were referred from the neuro-ophthalmology service for indirect CCFs with increased IOP and deterioration in visual acuity and/or cranial nerve function. All patients had symptom progression despite maximal medical therapy, including brimonidine (Alphagan; Allergan, Inc., Irvine, CA), timolol (Timoptic; Merck & Co., West Point, PA), and other medications. Table 1 summarizes patient demographics, severity of visual and cranial nerve impairment, and IOP at the time of embolization and at the most recent follow-up after embolization, as well as the vascular supply of each CCF and the sequence of endovascular procedures performed. Patients 1 to 5 had symptom onset a few weeks before presentation; Patient 6 presented within 24 hours of symptom onset. A photograph of Patient 6 at presentation demonstrates common signs of CCF, including severe conjunctival erythema, chemosis, complete bilateral IIIrd nerve palsies, and disconjugate gaze as a result of bilateral IVth and VIth nerve palsies (Fig. 1A) .
Each patient underwent angiography of both the ECA and ICA to delineate blood supply to the fistula (Fig. 2A) . The first patient underwent embolization with conscious sedation only but experienced significant discomfort during alcohol injection, prompting the use of general anesthesia with neurophysiological monitoring for the remainder of the patients. In all patients, a transvenous embolization was first attempted by catheterization of the inferior or superior petrosal sinuses. This could not be achieved in these patients, and a superior ophthalmic surgical exposure or transfacial vein catheterization was forgone in lieu of the following technique. The contribution from the ECA in Type C and D lesions was treated with polyvinyl alcohol particulate embolization of the ECA supply. Type B and D lesions were managed by advancing a nondetachable silicone balloon (Endeavor; Boston Scientific/ Medi-tech, Natick, MA) into the horizontal segment of the ICA just distal to the branches supplying the fistula but proximal to the ophthalmic artery. A microcatheter (TurboTracker 18; Boston Scientific/Target, Fremont, CA) was inserted through the 7-French study catheter and alongside the balloon catheter into the posterior genu of the cavernous ICA (proximal to the balloon). The balloon was inflated, and an angiogram through the microcatheter was performed to best visualize the cavernous ICA branches feeding the CCFs with no changes in the size or flow to the cavernous ICA branches (Fig. 2 , B and C). Angiography was repeated with repositioning of the balloon catheter and the endhole catheter several times until the optimal placement was achieved. In an effort to keep the ethanol as concentrated as possible, because dilution diminishes the effect, we did not mix contrast medium with the ethanol. To gauge a safe rate and amount of ethanol to be injected, we used a contrast injection of the same-size bolus of ethanol with the same-size syringe (usually a 1-ml syringe) before ethanol injection. We proceeded only after confirming minimal or no reflux down the ICA or into potentially dangerous anastamoses of the inferolateral trunk and ophthalmic artery. Individual injection volumes usually ranged between 0.3 and 1.0 ml, and total ethanol volume per ICA ranged between 3 and 5 ml. After each ethanol injection and before balloon deflation, vigorous irrigation was undertaken by injection of 20 ml of saline through the microcatheter while aspirating from the sideport of the guiding catheter. Repeat angiography via the microcatheter during balloon occlusion was then used to judge the progress of embolization. A 3-to 5-minute delayed angiogram was typically needed to confirm satisfactory vessel occlusion, because the effect of the alcohol was slightly delayed (Fig. 2D) . The balloon occlusion time usually ranged from 1 to 5 minutes, with multiple balloon inflations being necessary because any neurophysiological monitoring changes prompted balloon deflation. In Patient 6, electroencephalographic and somatosensory evoked potential monitoring showed no changes during prolonged balloon occlusion, prompting us not to deflate the balloon while waiting for the follow-up angiogram, which led to a total occlusion time of nearly 15 minutes with no ischemic sequelae.
RESULTS
All patients showed immediate and sustained decreases in IOP except for one, who normalized in a delayed manner ( Table 1) . Long-term follow-up (mean duration, 21 mo; range, 12-38 mo) showed visual acuity improvement to 20/30 or better in five patients, whereas Patient 6 improved from 20/ 100 bilaterally to 20/40 in the right eye and 20/60 in the left. IOP remained below 20 mm Hg in all six patients, with termination of medical therapy in two patients and a significant reduction in medical therapies in four patients. Cranial nerve deficits resolved in four patients, whereas two showed improvement in extraocular muscle function. Angiography on completion of the embolization procedures revealed complete obliteration of the indirect CCFs in three patients, whereas there was minimal residual filling in the other three. We did not perform follow-up angiography on these patients, given the continued clinical improvement of all six individuals (Fig.  1B) . For the three patients with residual flow and incomplete symptom resolution after embolization, we performed stereo- 
DISCUSSION
The first successful treatment of a possible CCF was reported by Travers, a British surgeon, who described a "thrilling tumor in which pulsation ceased upon compression of the vascular structures of the neck" (10) . He performed ligation of the common carotid artery, with a good clinical response. Many surgical approaches have since been introduced to treat CCFs, including combined muscle embolization through the cervical carotid with cavernous ICA surgical ligation by Hamby (10), cavernous ICA sacrifice under hypothermic arrest by Parkinson (17) , and surgical embolization of the cavernous sinus with hemostatic agents by Mullan (16) . Endovascular treatment of direct CCFs has moved to the forefront since the introduction of detachable balloons and is now the definitive treatment of high-flow traumatic or aneurysmal lesions because of its safety and efficacy (4, 5, 19) . Indirect CCFs (Types B-D), however, are rarely, if ever, amenable to balloon occlusion or particulate embolization, because they receive arterial supply from multiple ECA and/or cavernous ICA branches too numerous and too small for balloon occlusion. Close clinical observation is indicated for a patient with stable symptoms because of the spontaneous resolution rate of these lesions, ranging from 10 to 74%, and the 30% response rate to serial carotid compression (12) . However, indirect CCFs require vigilant observation, because they can cause rapid deterioration in vision and cranial nerve function as a result of retrograde filling of the superior ophthalmic vein and subsequent increasing IOP. (8) provided one of the few reports of embolization of cavernous ICA branches involving four indirect CCFs. They used polyvinyl alcohol in two patients, 50% dextrose in one patient, and isobutyl cyanoacrylate in one patient, with complete cure in all four patients during a period of 5 to 48 months of follow-up. Despite the promising results of that series, little support has followed in favor of attempting embolization of ICA branches.
Indirect CCF embolization via a transvenous approach through the superior ophthalmic vein either surgically or endovascularly or via the facial vein or through the inferior petrosal sinus, superior petrosal sinus, or cortical draining vein using an endovascular approach has been successful (3, 9, 14, 15). Halbach et al. (7) report 81% complete cure and 19% partial cure in a series of 54 patients treated with transvenous embolization using balloons, liquid adhesives, and/or coils, with a 4% complication rate. Patients in our series had either no angiographic evidence of an inferior petrosal sinus (unable to catheterize the inferior petrosal sinus despite numerous attempts) or severe angulation of the superior ophthalmic vein, placing it at risk for catheter perforation and retro-orbital hemorrhage. These findings made a transvenous approach impossible. We believed that the presence of a distinct region of feeders from the cavernous carotid would allow our technique to be a safe and effective alternative.
Yakes et al. (20) first reported the use of absolute ethanol in the endovascular management of cerebrovascular malformations in 1997. His group found that absolute ethanol caused immediate endothelial denudation and fractured the vessel wall to the level of the internal elastic lamina without causing angionecrosis or brain necrosis. This resulted in vessel sclerosis without recanalization. Absolute ethanol, however, is a dangerous embolization agent, given the immediate and permanent vessel occlusion it causes if injected into normal brain. The series by Yakes et al. (20) reported complications (only one permanent) in 8 of 17 patients, including hemiparesis, numbness, cognitive dysfunction, and hemianopsia. We chose alcohol for our patients because of its ability, as a liquid, to penetrate the cavernous ICA branches that were not large enough for direct microcatheterization and particulate embolization while minimizing the risk of embolism. However, Phatouros et al. (18) reported a patient with diabetes insipidus who required deamino-8-d-arginine vasopressin therapy for 3 months after injection of 50% dextrose and pure ethanol into an enlarged meningohypophyseal trunk supplying a CCF in which the inferior hypophyseal artery did not opacify during selective preembolization meningohypophyseal injection. In addition to pituitary dysfunction from meningohypophyseal occlusion via the hypophyseal artery, occlusion of the inferolateral trunk can lead to Cranial Nerve III, IV, and/or VI neuropathies or even blindness because of potential connections with the eye via the deep recurrent ophthalmic artery from the inferolateral trunk. A nondetachable balloon was inflated proximal to the ophthalmic artery during embolization of the cavernous ICA feeders to protect the eye and brain from ischemic injury. Venous thrombosis was unlikely, because any ethanol that entered the CCF venous drainage system was diluted and inactivated. We experienced only one procedure-related complication involving cavernous sinus thrombosis causing transient symptom exacerbation that eventually resolved over 4 weeks. This patient (Patient 1) had possible ethanol-induced occlusion of venous drainage from the cavernous sinus. Once collateral venous outflow developed over a few weeks, the worsened symptoms resolved.
Five of the six patients experienced an immediate reduction in IOP and improvement of visual acuity. We performed adjunctive embolization of ECA branches at the time of or within a few days of the cavernous carotid embolization for all Type D lesions to minimize the risk of recurrence by establishment of new collateral branches. For the three patients with residual flow and incomplete symptom resolution after embolization, we performed stereotactic radiosurgery after embolization, with further clinical improvement. We have not obtained follow-up angiography, given no clinical recurrences, although concern for long-term ICA patency after ethanol embolization may prompt us to obtain a computed tomographic angiogram or magnetic resonance angiogram in the future. We conclude that absolute ethanol embolization of cavernous ICA branches supplying indirect CCFs in association with temporary distal balloon protection is safe and effective in providing immediate relief of rapidly declining visual and extraocular motility function and rising IOPs. This technique has become an integral tool in the multimodal management of this complex vascular anomaly.
COMMENTS T
his article describes the usefulness of ethanol infusion into the cavernous internal carotid artery (ICA) with distal temporary balloon occlusion for treatment of indirect carotidcavernous fistulae (CCFs). Transvenous coil embolization of the cavernous sinus is a safe and effective method of treatment for these lesions, but lack of venous access can preclude this approach. In such cases or when residual fistula is apparent, one can be left with the prospect of selectively catheterizing small and tortuous cavernous ICA branches, which may be the dominant supply to these fistulae. The authors describe a novel solution to this problem, with marked improvement in symptomatology and intraocular pressure (IOP) measurements in all six of their patients. Despite their encouraging results, the number of patients is small, and the potential for injury to neural structures as a result of ethanol infusion into the cavernous ICA exists. We would advocate conservative measures, such as carotid compression and/or palliative embolization of external carotid artery feeders, and leave the described procedure as a last resort until the results can be substantiated by a larger patient experience.
Perry P. Ng Randall T. Higashida
Interventional Neuroradiologists San Francisco, California K oebbe et al. report a series of six patients with indirect CCFs who underwent endovascular treatment with ethanol embolization of ICA feeding arteries. Ethanol injection is potentially dangerous, but it may be an attractive alternative to the transvenous approach. In this small series, the authors have shown that ethanol embolization can be done safely. However, some questions about this technique remain. First, only three of the six patients had fistula obliteration and symptom resolution with embolization. The other three patients had incomplete resolution of the CCFs, demonstrated by residual flow on angiography after embolization and continued symptoms. These patients went on to have further treat-ment with stereotactic radiosurgery. These results raise questions about the efficacy of ethanol embolization for indirect CCFs. Secondly, the mean follow-up period of 21 months does not assure us that this treatment is truly durable. Larger case series and longer clinical follow-up in the future should shed light on these issues.
Mark R. Harrigan L. Nelson Hopkins
Buffalo, New York K oebbe et al. describe their experience in the treatment of six patients with worsening visual acuity treated with embolization of their CCFs with absolute ethanol and balloon occlusion. Five of the six patients in their group experienced immediate, sustained relief and reduction of IOP. One patient, however, did develop cavernous sinus thrombosis, which caused a worsening of the symptoms, albeit gradual, and these improved gradually over time. There is no question that absolute ethanol is a very effective embolic agent, as has been shown in peripheral interventional radiology.
The risk of using this agent intracranially is not insignificant, and I think that the complications that Yakes et al. (1) specified were quite high in terms of neurological events. There are other methods that carry less risk than using balloon occlusion in ethanol infusion and have very good results and perhaps a lower incidence of cavernous sinus thrombosis. In addition, the effects of the alcohol on the carotid artery in the long term are as yet unknown. This is an extremely dangerous procedure; certainly, if no other options are available, this is a good alternative. However, I think catheterization via either the inferior petrosal sinus or transvenous approach, which carry much less risk, should be undertaken before quite so radical a procedure is performed, as the authors have recommended. The effects of alcohol on the central nervous system and peripheral nerves are well known to the neurological and neurosurgical community and cannot be taken lightly.
Robert H. Rosenwasser
Philadelphia, Pennsylvania
